| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Borderline Personality Disorder | 62 | 2023 | 737 | 10.560 |
Why?
|
| Personality Disorders | 19 | 2023 | 713 | 3.870 |
Why?
|
| Models, Statistical | 38 | 2023 | 5100 | 2.530 |
Why?
|
| Substance-Related Disorders | 27 | 2023 | 4254 | 1.790 |
Why?
|
| Longitudinal Studies | 62 | 2023 | 13980 | 1.750 |
Why?
|
| Data Interpretation, Statistical | 22 | 2021 | 2715 | 1.590 |
Why?
|
| Psychotherapy | 7 | 2023 | 1640 | 1.470 |
Why?
|
| Regression Analysis | 18 | 2016 | 6457 | 1.420 |
Why?
|
| Protein-Energy Malnutrition | 7 | 2013 | 188 | 1.220 |
Why?
|
| Cocaine-Related Disorders | 4 | 2020 | 460 | 1.160 |
Why?
|
| Psychotherapy, Group | 7 | 2019 | 407 | 1.100 |
Why?
|
| Biometry | 14 | 2010 | 558 | 1.000 |
Why?
|
| Affect | 7 | 2015 | 1473 | 0.960 |
Why?
|
| Likelihood Functions | 15 | 2023 | 1004 | 0.890 |
Why?
|
| Interpersonal Relations | 13 | 2019 | 1424 | 0.890 |
Why?
|
| Research Design | 13 | 2023 | 5983 | 0.880 |
Why?
|
| Tranquilizing Agents | 1 | 2022 | 59 | 0.870 |
Why?
|
| Follow-Up Studies | 61 | 2023 | 39001 | 0.840 |
Why?
|
| Social Adjustment | 6 | 2017 | 629 | 0.830 |
Why?
|
| Iodine | 2 | 2022 | 286 | 0.760 |
Why?
|
| Suicide | 7 | 2021 | 1476 | 0.740 |
Why?
|
| Infant Nutrition Disorders | 4 | 2014 | 73 | 0.730 |
Why?
|
| Child Behavior Disorders | 7 | 2017 | 805 | 0.730 |
Why?
|
| Self Report | 11 | 2019 | 3550 | 0.730 |
Why?
|
| Interview, Psychological | 9 | 2016 | 812 | 0.720 |
Why?
|
| Adult | 152 | 2023 | 213889 | 0.700 |
Why?
|
| Self Mutilation | 3 | 2017 | 58 | 0.680 |
Why?
|
| Adult Survivors of Child Abuse | 3 | 2020 | 260 | 0.670 |
Why?
|
| Patient Dropouts | 4 | 2006 | 420 | 0.670 |
Why?
|
| Analgesics, Opioid | 12 | 2022 | 3677 | 0.670 |
Why?
|
| Bipolar Disorder | 12 | 2021 | 5027 | 0.670 |
Why?
|
| Statistics as Topic | 5 | 2014 | 2369 | 0.660 |
Why?
|
| Opioid-Related Disorders | 14 | 2020 | 2064 | 0.660 |
Why?
|
| Personality | 4 | 2020 | 552 | 0.660 |
Why?
|
| Young Adult | 70 | 2020 | 56392 | 0.650 |
Why?
|
| Depressive Disorder, Major | 11 | 2023 | 4635 | 0.650 |
Why?
|
| Female | 200 | 2022 | 380020 | 0.630 |
Why?
|
| Humans | 270 | 2023 | 743811 | 0.620 |
Why?
|
| Aggression | 5 | 2017 | 752 | 0.610 |
Why?
|
| Male | 181 | 2022 | 349776 | 0.600 |
Why?
|
| Personality Development | 3 | 2009 | 245 | 0.600 |
Why?
|
| Remission Induction | 7 | 2018 | 2384 | 0.600 |
Why?
|
| Psychiatric Status Rating Scales | 31 | 2020 | 6030 | 0.580 |
Why?
|
| Intelligence | 6 | 2018 | 920 | 0.580 |
Why?
|
| Prospective Studies | 52 | 2023 | 53250 | 0.570 |
Why?
|
| Mental Competency | 1 | 2018 | 176 | 0.570 |
Why?
|
| Linear Models | 13 | 2023 | 5952 | 0.570 |
Why?
|
| Time Factors | 24 | 2020 | 40038 | 0.560 |
Why?
|
| Sexual Partners | 4 | 2018 | 728 | 0.550 |
Why?
|
| Impulsive Behavior | 3 | 2021 | 316 | 0.540 |
Why?
|
| Dilatation and Curettage | 1 | 2015 | 56 | 0.530 |
Why?
|
| Confidence Intervals | 6 | 2014 | 2971 | 0.530 |
Why?
|
| Conduct Disorder | 4 | 2012 | 241 | 0.520 |
Why?
|
| Mifepristone | 2 | 2015 | 150 | 0.510 |
Why?
|
| Abortion, Induced | 4 | 2015 | 458 | 0.510 |
Why?
|
| Misoprostol | 2 | 2015 | 95 | 0.510 |
Why?
|
| Mental Status Schedule | 1 | 2015 | 321 | 0.500 |
Why?
|
| Adolescent Behavior | 4 | 2019 | 1151 | 0.490 |
Why?
|
| Endpoint Determination | 1 | 2017 | 601 | 0.490 |
Why?
|
| Adolescent | 75 | 2021 | 85729 | 0.490 |
Why?
|
| Alcoholism | 10 | 2023 | 1907 | 0.480 |
Why?
|
| Psychotropic Drugs | 3 | 2015 | 893 | 0.480 |
Why?
|
| Severity of Illness Index | 13 | 2020 | 15526 | 0.480 |
Why?
|
| Electroconvulsive Therapy | 2 | 2019 | 477 | 0.460 |
Why?
|
| Antisocial Personality Disorder | 5 | 2016 | 227 | 0.460 |
Why?
|
| Risk | 7 | 2017 | 9677 | 0.460 |
Why?
|
| Probability | 6 | 2023 | 2505 | 0.440 |
Why?
|
| Diagnostic and Statistical Manual of Mental Disorders | 13 | 2013 | 1951 | 0.440 |
Why?
|
| Nerve Block | 1 | 2019 | 644 | 0.440 |
Why?
|
| Affective Disorders, Psychotic | 4 | 2017 | 191 | 0.430 |
Why?
|
| Domestic Violence | 3 | 2010 | 176 | 0.430 |
Why?
|
| Recurrence | 15 | 2019 | 8337 | 0.430 |
Why?
|
| Marriage | 1 | 2014 | 339 | 0.430 |
Why?
|
| Cognition Disorders | 9 | 2016 | 4041 | 0.420 |
Why?
|
| Defense Mechanisms | 1 | 2013 | 178 | 0.420 |
Why?
|
| Women | 1 | 2014 | 230 | 0.420 |
Why?
|
| Directly Observed Therapy | 2 | 2009 | 137 | 0.420 |
Why?
|
| Spouses | 2 | 2014 | 286 | 0.410 |
Why?
|
| Comorbidity | 21 | 2023 | 10380 | 0.400 |
Why?
|
| Family Characteristics | 3 | 2014 | 1000 | 0.390 |
Why?
|
| Child Abuse | 7 | 2020 | 1030 | 0.390 |
Why?
|
| Barbados | 10 | 2020 | 52 | 0.390 |
Why?
|
| Counseling | 10 | 2019 | 1523 | 0.390 |
Why?
|
| Parents | 6 | 2020 | 3403 | 0.390 |
Why?
|
| Cognitive Dissonance | 1 | 2010 | 13 | 0.390 |
Why?
|
| Self-Injurious Behavior | 3 | 2013 | 464 | 0.390 |
Why?
|
| Pain, Postoperative | 2 | 2019 | 1642 | 0.380 |
Why?
|
| Hypnotics and Sedatives | 3 | 2022 | 1161 | 0.370 |
Why?
|
| Analysis of Variance | 5 | 2009 | 6356 | 0.370 |
Why?
|
| Algorithms | 11 | 2020 | 13869 | 0.370 |
Why?
|
| Sex Offenses | 3 | 2013 | 354 | 0.360 |
Why?
|
| Child Nutritional Physiological Phenomena | 2 | 2011 | 303 | 0.360 |
Why?
|
| Rehabilitation, Vocational | 1 | 2010 | 82 | 0.360 |
Why?
|
| Cluster Analysis | 5 | 2015 | 2712 | 0.350 |
Why?
|
| Clinical Trials as Topic | 6 | 2017 | 7908 | 0.350 |
Why?
|
| Odds Ratio | 12 | 2016 | 9848 | 0.350 |
Why?
|
| Anti-Inflammatory Agents, Non-Steroidal | 1 | 2019 | 2281 | 0.340 |
Why?
|
| Computer Simulation | 13 | 2023 | 6188 | 0.340 |
Why?
|
| Social Security | 1 | 2009 | 101 | 0.340 |
Why?
|
| Naloxone | 6 | 2015 | 365 | 0.340 |
Why?
|
| Normal Distribution | 3 | 2020 | 280 | 0.330 |
Why?
|
| Randomized Controlled Trials as Topic | 9 | 2020 | 9944 | 0.330 |
Why?
|
| Adaptation, Psychological | 7 | 2019 | 2575 | 0.330 |
Why?
|
| Crime Victims | 3 | 2019 | 322 | 0.330 |
Why?
|
| Logistic Models | 17 | 2020 | 13404 | 0.330 |
Why?
|
| Data Collection | 5 | 2011 | 3339 | 0.320 |
Why?
|
| Dietetics | 1 | 2008 | 35 | 0.320 |
Why?
|
| Family Conflict | 1 | 2009 | 95 | 0.320 |
Why?
|
| Anxiety Disorders | 9 | 2021 | 2684 | 0.320 |
Why?
|
| Bulimia Nervosa | 1 | 2010 | 177 | 0.320 |
Why?
|
| Suicide, Attempted | 5 | 2019 | 1218 | 0.320 |
Why?
|
| Patient Education as Topic | 1 | 2018 | 2278 | 0.310 |
Why?
|
| Malnutrition | 3 | 2020 | 625 | 0.300 |
Why?
|
| Multivariate Analysis | 13 | 2021 | 12243 | 0.300 |
Why?
|
| Tuberculosis | 5 | 2013 | 1914 | 0.300 |
Why?
|
| Intelligence Tests | 5 | 2016 | 503 | 0.300 |
Why?
|
| Treatment Outcome | 28 | 2020 | 63042 | 0.300 |
Why?
|
| Prevalence | 21 | 2019 | 15211 | 0.280 |
Why?
|
| Self Concept | 5 | 2018 | 1024 | 0.280 |
Why?
|
| Dissociative Disorders | 1 | 2008 | 231 | 0.280 |
Why?
|
| Narcotic Antagonists | 7 | 2016 | 562 | 0.280 |
Why?
|
| Mental Disorders | 9 | 2019 | 6593 | 0.280 |
Why?
|
| Bullying | 2 | 2019 | 210 | 0.270 |
Why?
|
| Community Mental Health Services | 1 | 2009 | 386 | 0.270 |
Why?
|
| Interviews as Topic | 6 | 2014 | 2538 | 0.270 |
Why?
|
| Opiate Substitution Treatment | 5 | 2019 | 404 | 0.270 |
Why?
|
| Sleep Initiation and Maintenance Disorders | 3 | 2013 | 1004 | 0.260 |
Why?
|
| Pregnancy Outcome | 1 | 2015 | 2794 | 0.250 |
Why?
|
| Child | 52 | 2020 | 77637 | 0.250 |
Why?
|
| Depression | 11 | 2019 | 7760 | 0.250 |
Why?
|
| Alcohol Deterrents | 2 | 2016 | 39 | 0.250 |
Why?
|
| Stress, Psychological | 6 | 2020 | 4245 | 0.250 |
Why?
|
| Sex Factors | 12 | 2019 | 10394 | 0.250 |
Why?
|
| Community Health Services | 1 | 2009 | 650 | 0.240 |
Why?
|
| Socioeconomic Factors | 13 | 2014 | 7784 | 0.240 |
Why?
|
| Sample Size | 5 | 2014 | 841 | 0.240 |
Why?
|
| Mood Disorders | 3 | 2021 | 1104 | 0.240 |
Why?
|
| Mental Health Services | 2 | 2010 | 1643 | 0.240 |
Why?
|
| Attention Deficit and Disruptive Behavior Disorders | 2 | 2003 | 304 | 0.240 |
Why?
|
| Inpatients | 9 | 2019 | 2515 | 0.240 |
Why?
|
| Depressive Disorder | 6 | 2013 | 3744 | 0.240 |
Why?
|
| Schizophrenia | 7 | 2021 | 6865 | 0.230 |
Why?
|
| Epidemiologic Methods | 2 | 2006 | 1364 | 0.230 |
Why?
|
| Buprenorphine | 6 | 2015 | 640 | 0.230 |
Why?
|
| Middle Aged | 62 | 2019 | 213241 | 0.230 |
Why?
|
| Adult Children | 2 | 2016 | 100 | 0.230 |
Why?
|
| Marijuana Abuse | 3 | 2017 | 403 | 0.220 |
Why?
|
| Age Factors | 16 | 2017 | 18355 | 0.210 |
Why?
|
| Ovarian Neoplasms | 1 | 2019 | 4839 | 0.210 |
Why?
|
| Criminals | 2 | 2015 | 62 | 0.210 |
Why?
|
| Sex Characteristics | 4 | 2018 | 2583 | 0.210 |
Why?
|
| Prognosis | 7 | 2019 | 29052 | 0.210 |
Why?
|
| Massachusetts | 11 | 2014 | 8660 | 0.210 |
Why?
|
| Hospitalization | 10 | 2019 | 10259 | 0.200 |
Why?
|
| Meta-Analysis as Topic | 3 | 2014 | 1340 | 0.200 |
Why?
|
| Developing Countries | 3 | 2016 | 2815 | 0.200 |
Why?
|
| England | 2 | 2021 | 522 | 0.200 |
Why?
|
| Pre-Eclampsia | 2 | 2022 | 1200 | 0.200 |
Why?
|
| Diagnosis | 1 | 2002 | 154 | 0.200 |
Why?
|
| Wales | 1 | 2021 | 85 | 0.200 |
Why?
|
| Anorexia Nervosa | 1 | 2010 | 1286 | 0.190 |
Why?
|
| Anxiety | 2 | 2014 | 4288 | 0.190 |
Why?
|
| Publishing | 1 | 2008 | 833 | 0.190 |
Why?
|
| Telemedicine | 1 | 2018 | 2874 | 0.190 |
Why?
|
| Chi-Square Distribution | 5 | 2023 | 3503 | 0.190 |
Why?
|
| Diagnosis, Dual (Psychiatry) | 5 | 2015 | 295 | 0.190 |
Why?
|
| Health Status | 5 | 2009 | 4031 | 0.180 |
Why?
|
| Depersonalization | 1 | 2020 | 39 | 0.180 |
Why?
|
| Employment | 3 | 2018 | 1132 | 0.180 |
Why?
|
| Social Environment | 4 | 2012 | 1022 | 0.180 |
Why?
|
| Psychometrics | 5 | 2020 | 3000 | 0.180 |
Why?
|
| Social Support | 7 | 2019 | 2118 | 0.180 |
Why?
|
| Disulfiram | 1 | 2020 | 58 | 0.180 |
Why?
|
| Antipsychotic Agents | 6 | 2018 | 3057 | 0.180 |
Why?
|
| United States | 29 | 2021 | 69859 | 0.170 |
Why?
|
| Disabled Persons | 1 | 2009 | 1214 | 0.170 |
Why?
|
| Adolescent Development | 2 | 2014 | 279 | 0.170 |
Why?
|
| Republic of Korea | 1 | 2021 | 538 | 0.170 |
Why?
|
| Maternal Behavior | 3 | 2011 | 311 | 0.170 |
Why?
|
| Family Health | 2 | 2016 | 1280 | 0.170 |
Why?
|
| Rape | 2 | 2017 | 133 | 0.170 |
Why?
|
| Abdominal Muscles | 1 | 2019 | 166 | 0.160 |
Why?
|
| Personality Inventory | 3 | 2013 | 1030 | 0.160 |
Why?
|
| Hallucinogens | 1 | 2021 | 177 | 0.160 |
Why?
|
| Physicians, Family | 3 | 2010 | 345 | 0.160 |
Why?
|
| Anti-HIV Agents | 5 | 2020 | 4255 | 0.160 |
Why?
|
| Stress Disorders, Post-Traumatic | 5 | 2012 | 4266 | 0.160 |
Why?
|
| Substance Withdrawal Syndrome | 2 | 2021 | 632 | 0.160 |
Why?
|
| Motor Skills Disorders | 1 | 2018 | 90 | 0.160 |
Why?
|
| Temperament | 3 | 2018 | 283 | 0.160 |
Why?
|
| Nutrition Surveys | 3 | 2022 | 1660 | 0.160 |
Why?
|
| New England | 5 | 2017 | 1022 | 0.160 |
Why?
|
| Resilience, Psychological | 2 | 2019 | 677 | 0.160 |
Why?
|
| Antimanic Agents | 3 | 2011 | 522 | 0.160 |
Why?
|
| Psychotic Disorders | 5 | 2019 | 3044 | 0.160 |
Why?
|
| Social Identification | 2 | 2016 | 103 | 0.160 |
Why?
|
| Cohort Studies | 22 | 2020 | 40545 | 0.150 |
Why?
|
| Risk Factors | 30 | 2019 | 72252 | 0.150 |
Why?
|
| Pregnancy Trimesters | 1 | 2018 | 192 | 0.150 |
Why?
|
| Australia | 1 | 2021 | 1167 | 0.150 |
Why?
|
| Smoking | 9 | 2023 | 8984 | 0.150 |
Why?
|
| Homicide | 2 | 2018 | 287 | 0.150 |
Why?
|
| Residential Treatment | 2 | 2019 | 111 | 0.150 |
Why?
|
| Weight Gain | 4 | 2021 | 2294 | 0.150 |
Why?
|
| Life Change Events | 5 | 2012 | 938 | 0.150 |
Why?
|
| Colectomy | 2 | 2014 | 680 | 0.150 |
Why?
|
| Violence | 3 | 2012 | 909 | 0.150 |
Why?
|
| Individuality | 1 | 2019 | 307 | 0.150 |
Why?
|
| Cognition | 5 | 2013 | 6759 | 0.140 |
Why?
|
| Sensitivity and Specificity | 7 | 2015 | 14714 | 0.140 |
Why?
|
| Naltrexone | 3 | 2016 | 307 | 0.140 |
Why?
|
| Anger | 2 | 2013 | 401 | 0.140 |
Why?
|
| Perceptual Disorders | 1 | 2018 | 194 | 0.140 |
Why?
|
| Brazil | 1 | 2021 | 1264 | 0.140 |
Why?
|
| Anti-Asthmatic Agents | 1 | 2001 | 536 | 0.140 |
Why?
|
| Prescription Drugs | 2 | 2014 | 593 | 0.140 |
Why?
|
| Ataxia | 1 | 2018 | 304 | 0.140 |
Why?
|
| Pregnancy Complications | 5 | 2015 | 2861 | 0.140 |
Why?
|
| Rhode Island | 6 | 2016 | 347 | 0.140 |
Why?
|
| Family Relations | 2 | 2012 | 321 | 0.140 |
Why?
|
| Child, Preschool | 19 | 2019 | 40964 | 0.130 |
Why?
|
| Internal-External Control | 2 | 2010 | 363 | 0.130 |
Why?
|
| Social Class | 6 | 2020 | 1997 | 0.130 |
Why?
|
| Cross-Sectional Studies | 14 | 2017 | 25032 | 0.130 |
Why?
|
| Case-Control Studies | 7 | 2017 | 21733 | 0.130 |
Why?
|
| Single-Blind Method | 3 | 2015 | 1586 | 0.130 |
Why?
|
| Personality Assessment | 2 | 2019 | 647 | 0.130 |
Why?
|
| Growth Disorders | 2 | 2015 | 645 | 0.130 |
Why?
|
| Child Development | 2 | 2018 | 2212 | 0.130 |
Why?
|
| Abortifacient Agents, Nonsteroidal | 1 | 2015 | 62 | 0.130 |
Why?
|
| Psychopathology | 2 | 2012 | 407 | 0.130 |
Why?
|
| Cannabis | 1 | 2021 | 440 | 0.130 |
Why?
|
| Binomial Distribution | 1 | 2014 | 25 | 0.130 |
Why?
|
| Protein Deficiency | 1 | 2015 | 61 | 0.130 |
Why?
|
| Seasons | 1 | 2021 | 1493 | 0.130 |
Why?
|
| Mothers | 9 | 2020 | 2166 | 0.130 |
Why?
|
| Mutagenicity Tests | 1 | 1994 | 46 | 0.130 |
Why?
|
| Health Status Disparities | 3 | 2013 | 1796 | 0.130 |
Why?
|
| Movement Disorders | 1 | 2018 | 448 | 0.130 |
Why?
|
| Photoperiod | 1 | 2015 | 136 | 0.130 |
Why?
|
| Income | 3 | 2016 | 1913 | 0.120 |
Why?
|
| Combined Modality Therapy | 7 | 2017 | 8637 | 0.120 |
Why?
|
| Diet, Protein-Restricted | 1 | 2015 | 71 | 0.120 |
Why?
|
| Substance Abuse Detection | 2 | 2014 | 283 | 0.120 |
Why?
|
| Cocaine | 1 | 2020 | 1007 | 0.120 |
Why?
|
| Pain Measurement | 4 | 2019 | 3420 | 0.120 |
Why?
|
| Affective Symptoms | 2 | 2019 | 405 | 0.120 |
Why?
|
| Human Development | 1 | 2015 | 124 | 0.120 |
Why?
|
| Hospitals, Psychiatric | 1 | 2015 | 332 | 0.120 |
Why?
|
| Toxicology | 1 | 1994 | 106 | 0.120 |
Why?
|
| Infant Nutritional Physiological Phenomena | 1 | 2016 | 347 | 0.120 |
Why?
|
| Emotions | 2 | 2023 | 2656 | 0.120 |
Why?
|
| Shame | 1 | 2014 | 78 | 0.120 |
Why?
|
| Substance Abuse Treatment Centers | 1 | 2014 | 168 | 0.120 |
Why?
|
| Case Management | 1 | 2015 | 286 | 0.120 |
Why?
|
| Prenatal Nutritional Physiological Phenomena | 1 | 2015 | 159 | 0.110 |
Why?
|
| Behavior Therapy | 3 | 2017 | 862 | 0.110 |
Why?
|
| Paranoid Disorders | 1 | 2013 | 60 | 0.110 |
Why?
|
| Multicenter Studies as Topic | 1 | 2018 | 1676 | 0.110 |
Why?
|
| Cardiovascular Diseases | 7 | 2019 | 15142 | 0.110 |
Why?
|
| Pregnancy | 14 | 2022 | 29140 | 0.110 |
Why?
|
| Child Health Services | 1 | 1999 | 666 | 0.110 |
Why?
|
| Child Abuse, Sexual | 2 | 2017 | 383 | 0.110 |
Why?
|
| Concept Formation | 1 | 2014 | 158 | 0.110 |
Why?
|
| Internet | 2 | 2018 | 3058 | 0.110 |
Why?
|
| Paranoid Personality Disorder | 1 | 2012 | 8 | 0.110 |
Why?
|
| Passive-Aggressive Personality Disorder | 1 | 2012 | 5 | 0.110 |
Why?
|
| Dependent Personality Disorder | 1 | 2012 | 13 | 0.110 |
Why?
|
| Surgical Instruments | 1 | 2015 | 395 | 0.110 |
Why?
|
| Anticholesteremic Agents | 1 | 2000 | 979 | 0.110 |
Why?
|
| Pregnancy Trimester, Second | 1 | 2015 | 732 | 0.110 |
Why?
|
| Prenatal Exposure Delayed Effects | 3 | 2010 | 2407 | 0.110 |
Why?
|
| Biostatistics | 2 | 2011 | 161 | 0.110 |
Why?
|
| Diseases in Twins | 2 | 2004 | 450 | 0.110 |
Why?
|
| Reference Values | 4 | 2001 | 4974 | 0.110 |
Why?
|
| Mental Health | 3 | 2017 | 3012 | 0.110 |
Why?
|
| Sampling Studies | 2 | 2015 | 622 | 0.110 |
Why?
|
| Attention Deficit Disorder with Hyperactivity | 4 | 2012 | 3655 | 0.100 |
Why?
|
| Child of Impaired Parents | 2 | 2013 | 455 | 0.100 |
Why?
|
| Vascular Diseases | 1 | 2020 | 1161 | 0.100 |
Why?
|
| Fetal Blood | 1 | 2018 | 1318 | 0.100 |
Why?
|
| Nutritional Status | 2 | 2016 | 1608 | 0.100 |
Why?
|
| Urinalysis | 1 | 2014 | 369 | 0.100 |
Why?
|
| Health Status Indicators | 2 | 2016 | 970 | 0.100 |
Why?
|
| Intracranial Aneurysm | 1 | 2021 | 1197 | 0.100 |
Why?
|
| HIV Infections | 6 | 2020 | 16715 | 0.100 |
Why?
|
| Forecasting | 1 | 2001 | 2950 | 0.100 |
Why?
|
| Mammography | 2 | 2014 | 2475 | 0.100 |
Why?
|
| Quality of Life | 3 | 2021 | 12788 | 0.100 |
Why?
|
| Colorectal Neoplasms | 5 | 2014 | 6773 | 0.100 |
Why?
|
| Patient Care | 1 | 2017 | 638 | 0.100 |
Why?
|
| Infant | 14 | 2020 | 35122 | 0.100 |
Why?
|
| Remission, Spontaneous | 2 | 2010 | 382 | 0.100 |
Why?
|
| Aged | 30 | 2019 | 163178 | 0.100 |
Why?
|
| Menarche | 1 | 2014 | 516 | 0.100 |
Why?
|
| Anti-Retroviral Agents | 2 | 2019 | 1714 | 0.100 |
Why?
|
| Schizophrenic Psychology | 1 | 2018 | 1671 | 0.100 |
Why?
|
| Fetal Hypoxia | 1 | 2011 | 29 | 0.100 |
Why?
|
| Pain | 4 | 2023 | 4987 | 0.100 |
Why?
|
| Sexual Behavior | 2 | 2011 | 2049 | 0.100 |
Why?
|
| Obesity | 6 | 2006 | 12744 | 0.100 |
Why?
|
| Healthcare Disparities | 6 | 2013 | 3155 | 0.100 |
Why?
|
| Health Care Surveys | 3 | 2015 | 2453 | 0.100 |
Why?
|
| Mass Screening | 5 | 2019 | 5251 | 0.100 |
Why?
|
| Vaginal Smears | 1 | 2014 | 511 | 0.100 |
Why?
|
| Primary Health Care | 4 | 2013 | 4556 | 0.090 |
Why?
|
| Civil Disorders | 1 | 2010 | 8 | 0.090 |
Why?
|
| Incidence | 7 | 2020 | 20948 | 0.090 |
Why?
|
| Models, Biological | 2 | 2008 | 9582 | 0.090 |
Why?
|
| Neuropsychological Tests | 5 | 2019 | 6976 | 0.090 |
Why?
|
| Blood Pressure Determination | 1 | 2014 | 633 | 0.090 |
Why?
|
| Reproducibility of Results | 6 | 2015 | 19894 | 0.090 |
Why?
|
| Anti-Arrhythmia Agents | 1 | 2014 | 788 | 0.090 |
Why?
|
| Psychomotor Performance | 1 | 2018 | 1895 | 0.090 |
Why?
|
| Russia | 4 | 2013 | 408 | 0.090 |
Why?
|
| Predictive Value of Tests | 7 | 2015 | 15067 | 0.090 |
Why?
|
| South Africa | 3 | 2020 | 1731 | 0.090 |
Why?
|
| United States Food and Drug Administration | 1 | 2017 | 1582 | 0.090 |
Why?
|
| Psychiatric Department, Hospital | 1 | 2010 | 135 | 0.090 |
Why?
|
| Dietary Proteins | 1 | 2015 | 962 | 0.090 |
Why?
|
| Diabetes Mellitus | 4 | 2010 | 5752 | 0.090 |
Why?
|
| Aftercare | 1 | 2015 | 870 | 0.090 |
Why?
|
| Diagnostic Self Evaluation | 1 | 2011 | 230 | 0.090 |
Why?
|
| Behavior, Addictive | 1 | 2015 | 462 | 0.090 |
Why?
|
| Crime | 1 | 2010 | 215 | 0.080 |
Why?
|
| Cause of Death | 2 | 2018 | 3580 | 0.080 |
Why?
|
| Heart Arrest | 1 | 2019 | 1470 | 0.080 |
Why?
|
| Bayes Theorem | 1 | 2017 | 2307 | 0.080 |
Why?
|
| Fetal Development | 1 | 2015 | 767 | 0.080 |
Why?
|
| Vitamin D Deficiency | 1 | 2018 | 1342 | 0.080 |
Why?
|
| Acupuncture Points | 1 | 2009 | 101 | 0.080 |
Why?
|
| Antiretroviral Therapy, Highly Active | 1 | 2017 | 1872 | 0.080 |
Why?
|
| Psychological Tests | 1 | 2011 | 647 | 0.080 |
Why?
|
| Perinatal Care | 1 | 2011 | 227 | 0.080 |
Why?
|
| Poisson Distribution | 3 | 2018 | 513 | 0.080 |
Why?
|
| Alcohol Drinking | 4 | 2016 | 3965 | 0.080 |
Why?
|
| Social Behavior | 2 | 2017 | 1126 | 0.080 |
Why?
|
| Physician Incentive Plans | 1 | 2009 | 161 | 0.080 |
Why?
|
| Risk-Taking | 2 | 2011 | 986 | 0.080 |
Why?
|
| Disability Evaluation | 2 | 2013 | 1828 | 0.080 |
Why?
|
| Risk Assessment | 5 | 2015 | 23327 | 0.080 |
Why?
|
| Adrenergic beta-Antagonists | 1 | 2014 | 1240 | 0.080 |
Why?
|
| Patient Admission | 1 | 2016 | 1380 | 0.080 |
Why?
|
| Double-Blind Method | 4 | 2018 | 12020 | 0.080 |
Why?
|
| Antidepressive Agents | 2 | 2011 | 2837 | 0.080 |
Why?
|
| Irritable Bowel Syndrome | 1 | 2013 | 445 | 0.080 |
Why?
|
| Respiratory Sounds | 5 | 2006 | 696 | 0.080 |
Why?
|
| Extensively Drug-Resistant Tuberculosis | 1 | 2008 | 92 | 0.080 |
Why?
|
| Alcohol-Related Disorders | 1 | 2010 | 234 | 0.080 |
Why?
|
| Patient Acceptance of Health Care | 2 | 2012 | 3020 | 0.070 |
Why?
|
| Body Height | 3 | 2005 | 1579 | 0.070 |
Why?
|
| Self Disclosure | 1 | 2008 | 251 | 0.070 |
Why?
|
| Transcutaneous Electric Nerve Stimulation | 1 | 2009 | 162 | 0.070 |
Why?
|
| Genetic Predisposition to Disease | 6 | 2014 | 17439 | 0.070 |
Why?
|
| Cultural Competency | 1 | 2010 | 289 | 0.070 |
Why?
|
| Divorce | 2 | 2005 | 79 | 0.070 |
Why?
|
| Object Attachment | 1 | 2009 | 313 | 0.070 |
Why?
|
| Poverty | 3 | 2014 | 2660 | 0.070 |
Why?
|
| Preoperative Care | 1 | 2015 | 2251 | 0.070 |
Why?
|
| Clinical Trials, Phase III as Topic | 1 | 2010 | 841 | 0.070 |
Why?
|
| Health Services Accessibility | 4 | 2012 | 5136 | 0.070 |
Why?
|
| Adjustment Disorders | 1 | 2006 | 70 | 0.070 |
Why?
|
| Patient Care Management | 1 | 2009 | 306 | 0.070 |
Why?
|
| Benzodiazepines | 1 | 2012 | 1101 | 0.070 |
Why?
|
| Colonoscopy | 2 | 2012 | 1367 | 0.070 |
Why?
|
| Marital Status | 2 | 2005 | 437 | 0.070 |
Why?
|
| Perphenazine | 2 | 2018 | 34 | 0.070 |
Why?
|
| Long-Term Care | 1 | 2010 | 606 | 0.070 |
Why?
|
| Environment | 1 | 2012 | 1121 | 0.070 |
Why?
|
| Twin Studies as Topic | 1 | 2005 | 104 | 0.070 |
Why?
|
| Asthma | 3 | 2001 | 6010 | 0.070 |
Why?
|
| Anesthetics, Intravenous | 1 | 2009 | 417 | 0.070 |
Why?
|
| Mathematics | 3 | 1995 | 727 | 0.060 |
Why?
|
| Body Mass Index | 3 | 2020 | 12718 | 0.060 |
Why?
|
| Food | 1 | 2010 | 771 | 0.060 |
Why?
|
| Obsessive-Compulsive Disorder | 1 | 2014 | 1443 | 0.060 |
Why?
|
| Drug Prescriptions | 1 | 2014 | 1636 | 0.060 |
Why?
|
| Vitamin D | 1 | 2018 | 3222 | 0.060 |
Why?
|
| Developmental Disabilities | 1 | 2013 | 1452 | 0.060 |
Why?
|
| Aged, 80 and over | 10 | 2019 | 57744 | 0.060 |
Why?
|
| Acetaminophen | 1 | 2009 | 545 | 0.060 |
Why?
|
| Health Care Reform | 1 | 2014 | 1261 | 0.060 |
Why?
|
| Survival Analysis | 5 | 2009 | 10251 | 0.060 |
Why?
|
| Contraceptive Agents, Female | 1 | 2006 | 135 | 0.060 |
Why?
|
| Registries | 3 | 2019 | 8090 | 0.060 |
Why?
|
| Contraceptive Agents | 1 | 2006 | 151 | 0.060 |
Why?
|
| Personal Satisfaction | 1 | 2009 | 641 | 0.060 |
Why?
|
| Prostate-Specific Antigen | 1 | 2014 | 2471 | 0.060 |
Why?
|
| Conscious Sedation | 1 | 2009 | 527 | 0.060 |
Why?
|
| Kaplan-Meier Estimate | 2 | 2012 | 6539 | 0.060 |
Why?
|
| Forced Expiratory Volume | 2 | 2001 | 1740 | 0.060 |
Why?
|
| Carcinoma, Intraductal, Noninfiltrating | 1 | 2011 | 948 | 0.060 |
Why?
|
| Diabetes Complications | 2 | 2008 | 1360 | 0.060 |
Why?
|
| Circadian Rhythm | 1 | 2015 | 2620 | 0.060 |
Why?
|
| Acquired Immunodeficiency Syndrome | 2 | 2010 | 2232 | 0.060 |
Why?
|
| Health Maintenance Organizations | 1 | 2006 | 642 | 0.060 |
Why?
|
| Heart Rate | 1 | 2014 | 4091 | 0.060 |
Why?
|
| Aspirin | 2 | 2020 | 3283 | 0.060 |
Why?
|
| Air Pollution | 5 | 1997 | 2286 | 0.060 |
Why?
|
| Sanitation | 1 | 2003 | 93 | 0.060 |
Why?
|
| Family Practice | 1 | 2006 | 516 | 0.060 |
Why?
|
| Cholesterol, LDL | 3 | 2010 | 2354 | 0.060 |
Why?
|
| Medication Errors | 1 | 2009 | 798 | 0.060 |
Why?
|
| Ambulatory Care Facilities | 1 | 2009 | 934 | 0.060 |
Why?
|
| Low Back Pain | 1 | 2011 | 956 | 0.050 |
Why?
|
| Social Justice | 1 | 2007 | 457 | 0.050 |
Why?
|
| Risk Adjustment | 1 | 2006 | 594 | 0.050 |
Why?
|
| Colon | 1 | 2011 | 1772 | 0.050 |
Why?
|
| Contraception | 1 | 2006 | 359 | 0.050 |
Why?
|
| Selection Bias | 1 | 2004 | 371 | 0.050 |
Why?
|
| Amenorrhea | 1 | 2006 | 485 | 0.050 |
Why?
|
| Expressed Emotion | 1 | 2003 | 92 | 0.050 |
Why?
|
| Water Supply | 1 | 2003 | 214 | 0.050 |
Why?
|
| Antibiotics, Antineoplastic | 1 | 2006 | 690 | 0.050 |
Why?
|
| Doxorubicin | 2 | 2006 | 2234 | 0.050 |
Why?
|
| Didanosine | 3 | 2010 | 153 | 0.050 |
Why?
|
| School Health Services | 1 | 2005 | 375 | 0.050 |
Why?
|
| Analgesia | 1 | 2006 | 461 | 0.050 |
Why?
|
| Growth | 1 | 2003 | 376 | 0.050 |
Why?
|
| Puerto Rico | 1 | 2002 | 356 | 0.050 |
Why?
|
| Age Distribution | 3 | 2019 | 2899 | 0.050 |
Why?
|
| Population Dynamics | 1 | 2003 | 302 | 0.050 |
Why?
|
| Insurance, Health | 1 | 2014 | 2492 | 0.050 |
Why?
|
| Statistical Distributions | 1 | 2001 | 64 | 0.050 |
Why?
|
| Attitude of Health Personnel | 2 | 2008 | 3839 | 0.050 |
Why?
|
| Patient Readmission | 1 | 2015 | 3117 | 0.050 |
Why?
|
| Proportional Hazards Models | 3 | 2012 | 12354 | 0.050 |
Why?
|
| Hospitals, Teaching | 1 | 2006 | 1180 | 0.050 |
Why?
|
| Accidents | 1 | 2002 | 164 | 0.050 |
Why?
|
| Military Personnel | 1 | 2010 | 1133 | 0.050 |
Why?
|
| Child Welfare | 1 | 2005 | 523 | 0.050 |
Why?
|
| Age of Onset | 4 | 2011 | 3268 | 0.050 |
Why?
|
| Triamcinolone Acetonide | 1 | 2001 | 101 | 0.050 |
Why?
|
| Family | 3 | 2012 | 3144 | 0.050 |
Why?
|
| Program Evaluation | 1 | 2009 | 2483 | 0.050 |
Why?
|
| Retrospective Studies | 7 | 2019 | 77410 | 0.050 |
Why?
|
| Physical Fitness | 1 | 2005 | 732 | 0.050 |
Why?
|
| Vitamin A | 1 | 2003 | 615 | 0.050 |
Why?
|
| Anesthetics | 1 | 2006 | 539 | 0.050 |
Why?
|
| Practice Guidelines as Topic | 1 | 2017 | 7270 | 0.050 |
Why?
|
| Aging | 2 | 2013 | 8655 | 0.050 |
Why?
|
| Early Detection of Cancer | 2 | 2014 | 3089 | 0.050 |
Why?
|
| Antitubercular Agents | 1 | 2008 | 1320 | 0.050 |
Why?
|
| Population Surveillance | 2 | 2014 | 2614 | 0.040 |
Why?
|
| Random Allocation | 2 | 2015 | 2429 | 0.040 |
Why?
|
| Infant, Newborn | 4 | 2019 | 25609 | 0.040 |
Why?
|
| Pregnancy Trimester, First | 2 | 2018 | 853 | 0.040 |
Why?
|
| Zidovudine | 3 | 2010 | 620 | 0.040 |
Why?
|
| Secondary Prevention | 1 | 2006 | 1529 | 0.040 |
Why?
|
| Preventive Psychiatry | 1 | 2019 | 6 | 0.040 |
Why?
|
| Dose-Response Relationship, Drug | 3 | 2018 | 10940 | 0.040 |
Why?
|
| Precursor Cell Lymphoblastic Leukemia-Lymphoma | 2 | 2006 | 1520 | 0.040 |
Why?
|
| Lymph Nodes | 1 | 2011 | 3476 | 0.040 |
Why?
|
| Social Isolation | 1 | 2002 | 367 | 0.040 |
Why?
|
| Negativism | 1 | 2018 | 24 | 0.040 |
Why?
|
| Patients | 1 | 2006 | 899 | 0.040 |
Why?
|
| Life Style | 2 | 2019 | 3833 | 0.040 |
Why?
|
| Gender Identity | 2 | 2018 | 686 | 0.040 |
Why?
|
| Colonic Neoplasms | 1 | 2011 | 2542 | 0.040 |
Why?
|
| Glutamine | 1 | 2021 | 579 | 0.040 |
Why?
|
| CD4 Lymphocyte Count | 3 | 2010 | 2560 | 0.040 |
Why?
|
| Quality of Health Care | 2 | 2014 | 4370 | 0.040 |
Why?
|
| Urban Health | 2 | 2005 | 547 | 0.040 |
Why?
|
| Connecticut | 1 | 1999 | 366 | 0.040 |
Why?
|
| Tobacco Smoke Pollution | 3 | 2006 | 816 | 0.040 |
Why?
|
| Lung Diseases | 1 | 2008 | 1887 | 0.040 |
Why?
|
| Mental Recall | 1 | 2004 | 1206 | 0.040 |
Why?
|
| Models, Genetic | 2 | 2005 | 3492 | 0.040 |
Why?
|
| Immediate-Early Proteins | 1 | 2001 | 453 | 0.040 |
Why?
|
| Medication Adherence | 1 | 2009 | 2063 | 0.040 |
Why?
|
| Education | 1 | 2001 | 543 | 0.040 |
Why?
|
| Epidemiologic Studies | 1 | 2001 | 676 | 0.040 |
Why?
|
| Disease Progression | 5 | 2012 | 13273 | 0.040 |
Why?
|
| Coronary Disease | 2 | 2003 | 6078 | 0.040 |
Why?
|
| beta Carotene | 1 | 1999 | 527 | 0.040 |
Why?
|
| Hyperglycemia | 1 | 2006 | 1373 | 0.040 |
Why?
|
| Touch Perception | 1 | 2018 | 114 | 0.040 |
Why?
|
| Eye Color | 1 | 1996 | 36 | 0.040 |
Why?
|
| Disease | 1 | 2002 | 680 | 0.040 |
Why?
|
| Attitude to Health | 1 | 2006 | 2052 | 0.040 |
Why?
|
| Physician Assistants | 2 | 2010 | 192 | 0.030 |
Why?
|
| Risperidone | 1 | 2018 | 383 | 0.030 |
Why?
|
| Drug Therapy, Combination | 3 | 2013 | 6487 | 0.030 |
Why?
|
| Pregnancy Trimester, Third | 1 | 2018 | 571 | 0.030 |
Why?
|
| Kidney Failure, Chronic | 1 | 2009 | 2534 | 0.030 |
Why?
|
| Observer Variation | 1 | 2002 | 2592 | 0.030 |
Why?
|
| Glutamic Acid | 1 | 2021 | 1168 | 0.030 |
Why?
|
| Atrial Fibrillation | 1 | 2014 | 5033 | 0.030 |
Why?
|
| Postpartum Period | 1 | 2022 | 1086 | 0.030 |
Why?
|
| Taurine | 1 | 2016 | 94 | 0.030 |
Why?
|
| Peer Group | 1 | 2020 | 635 | 0.030 |
Why?
|
| gamma-Aminobutyric Acid | 1 | 2021 | 1118 | 0.030 |
Why?
|
| Nurse Practitioners | 2 | 2010 | 269 | 0.030 |
Why?
|
| Sex Distribution | 2 | 2011 | 2298 | 0.030 |
Why?
|
| Homing Behavior | 1 | 2015 | 5 | 0.030 |
Why?
|
| Pilot Projects | 3 | 2017 | 8316 | 0.030 |
Why?
|
| Space Perception | 1 | 2018 | 474 | 0.030 |
Why?
|
| Health Surveys | 2 | 2015 | 4036 | 0.030 |
Why?
|
| Temperance | 1 | 2015 | 89 | 0.030 |
Why?
|
| Immunoglobulin E | 1 | 2001 | 1463 | 0.030 |
Why?
|
| Emergency Service, Hospital | 1 | 2014 | 7658 | 0.030 |
Why?
|
| Specific Pathogen-Free Organisms | 1 | 2015 | 226 | 0.030 |
Why?
|
| Caseins | 1 | 2015 | 104 | 0.030 |
Why?
|
| Evidence-Based Medicine | 1 | 2006 | 3608 | 0.030 |
Why?
|
| Referral and Consultation | 1 | 2007 | 3530 | 0.030 |
Why?
|
| Boston | 3 | 2014 | 9310 | 0.030 |
Why?
|
| Community Health Centers | 1 | 2017 | 428 | 0.030 |
Why?
|
| Pediatrics | 1 | 2009 | 3474 | 0.030 |
Why?
|
| Paternal Exposure | 1 | 2015 | 89 | 0.030 |
Why?
|
| Vital Capacity | 1 | 1997 | 925 | 0.030 |
Why?
|
| Rats, Long-Evans | 1 | 2015 | 387 | 0.030 |
Why?
|
| Amphetamine-Related Disorders | 1 | 2014 | 67 | 0.030 |
Why?
|
| Reward | 1 | 2021 | 940 | 0.030 |
Why?
|
| Heroin | 1 | 2014 | 117 | 0.030 |
Why?
|
| Weight Loss | 1 | 2005 | 2625 | 0.030 |
Why?
|
| Drug Administration Schedule | 2 | 2014 | 4931 | 0.030 |
Why?
|
| Fiji | 1 | 2013 | 47 | 0.030 |
Why?
|
| Chronic Disease | 2 | 2006 | 9139 | 0.030 |
Why?
|
| Least-Squares Analysis | 1 | 1994 | 379 | 0.030 |
Why?
|
| Hospitals | 1 | 2007 | 3953 | 0.030 |
Why?
|
| Hospital Mortality | 1 | 2007 | 5316 | 0.030 |
Why?
|
| Heart Ventricles | 1 | 2006 | 3817 | 0.030 |
Why?
|
| Echocardiography | 1 | 2006 | 5096 | 0.030 |
Why?
|
| Health Behavior | 1 | 2005 | 2634 | 0.030 |
Why?
|
| Social Stigma | 1 | 2019 | 701 | 0.030 |
Why?
|
| Heart Diseases | 1 | 2006 | 2789 | 0.030 |
Why?
|
| Parent-Child Relations | 1 | 2017 | 746 | 0.030 |
Why?
|
| Research | 1 | 2001 | 1999 | 0.030 |
Why?
|
| Feeding Behavior | 1 | 2005 | 3187 | 0.030 |
Why?
|
| Glucocorticoids | 1 | 2001 | 2107 | 0.030 |
Why?
|
| Models, Theoretical | 1 | 2004 | 3587 | 0.030 |
Why?
|
| Wechsler Scales | 1 | 2012 | 260 | 0.030 |
Why?
|
| Breast Neoplasms | 3 | 2014 | 20827 | 0.030 |
Why?
|
| Primary Prevention | 1 | 2019 | 1167 | 0.030 |
Why?
|
| Blood Pressure | 2 | 2022 | 8551 | 0.030 |
Why?
|
| Abortifacient Agents, Steroidal | 1 | 2011 | 19 | 0.030 |
Why?
|
| Thiazoles | 1 | 2018 | 1482 | 0.020 |
Why?
|
| Chicago | 1 | 2012 | 240 | 0.020 |
Why?
|
| Carcinoembryonic Antigen | 1 | 2012 | 349 | 0.020 |
Why?
|
| Area Under Curve | 1 | 2015 | 1654 | 0.020 |
Why?
|
| Physicians | 1 | 2009 | 4569 | 0.020 |
Why?
|
| Poverty Areas | 1 | 2013 | 275 | 0.020 |
Why?
|
| Dibenzothiazepines | 1 | 2011 | 103 | 0.020 |
Why?
|
| ROC Curve | 2 | 2009 | 3527 | 0.020 |
Why?
|
| Patient Compliance | 2 | 2013 | 2683 | 0.020 |
Why?
|
| Narcotics | 1 | 2013 | 343 | 0.020 |
Why?
|
| HIV-1 | 2 | 2019 | 6939 | 0.020 |
Why?
|
| Respiratory Tract Diseases | 1 | 1996 | 722 | 0.020 |
Why?
|
| RNA, Viral | 1 | 2019 | 2901 | 0.020 |
Why?
|
| Nasal Decongestants | 1 | 2010 | 28 | 0.020 |
Why?
|
| Dietary Supplements | 2 | 2018 | 3292 | 0.020 |
Why?
|
| Mesentery | 1 | 2011 | 205 | 0.020 |
Why?
|
| Back Pain | 1 | 2014 | 544 | 0.020 |
Why?
|
| Sierra Leone | 1 | 2010 | 166 | 0.020 |
Why?
|
| Organ Size | 1 | 2015 | 2241 | 0.020 |
Why?
|
| Phenylephrine | 1 | 2010 | 301 | 0.020 |
Why?
|
| Fibromyalgia | 1 | 2014 | 388 | 0.020 |
Why?
|
| Lithium Compounds | 1 | 2011 | 225 | 0.020 |
Why?
|
| Tumor Necrosis Factor-alpha | 1 | 2001 | 4422 | 0.020 |
Why?
|
| Health Personnel | 1 | 2003 | 3217 | 0.020 |
Why?
|
| Self Efficacy | 1 | 2013 | 615 | 0.020 |
Why?
|
| Triazines | 1 | 2011 | 315 | 0.020 |
Why?
|
| Off-Label Use | 1 | 2010 | 169 | 0.020 |
Why?
|
| Educational Status | 1 | 2016 | 2540 | 0.020 |
Why?
|
| Bone Density | 1 | 2001 | 3460 | 0.020 |
Why?
|
| Coloring Agents | 1 | 2011 | 565 | 0.020 |
Why?
|
| Fathers | 1 | 2011 | 358 | 0.020 |
Why?
|
| Piperazines | 1 | 2018 | 2487 | 0.020 |
Why?
|
| Valproic Acid | 1 | 2011 | 445 | 0.020 |
Why?
|
| Medical Audit | 1 | 2009 | 466 | 0.020 |
Why?
|
| Platelet Aggregation Inhibitors | 1 | 2020 | 3070 | 0.020 |
Why?
|
| Polypharmacy | 1 | 2010 | 294 | 0.020 |
Why?
|
| HIV Seronegativity | 1 | 2008 | 211 | 0.020 |
Why?
|
| Hypertension | 3 | 2019 | 8480 | 0.020 |
Why?
|
| Professional Practice Location | 1 | 2007 | 58 | 0.020 |
Why?
|
| Mortality | 1 | 2019 | 2862 | 0.020 |
Why?
|
| Patient Selection | 2 | 2009 | 4210 | 0.020 |
Why?
|
| Group Practice | 1 | 2008 | 149 | 0.020 |
Why?
|
| Wisconsin | 1 | 2006 | 124 | 0.020 |
Why?
|
| Renal Replacement Therapy | 1 | 2009 | 258 | 0.020 |
Why?
|
| Sputum | 1 | 2008 | 476 | 0.020 |
Why?
|
| Osteoarthritis | 1 | 2014 | 1035 | 0.020 |
Why?
|
| Drug Monitoring | 1 | 2012 | 953 | 0.020 |
Why?
|
| SEER Program | 1 | 2011 | 1507 | 0.020 |
Why?
|
| Sweden | 1 | 2009 | 1341 | 0.020 |
Why?
|
| Zalcitabine | 1 | 2005 | 42 | 0.020 |
Why?
|
| Students | 1 | 2015 | 1647 | 0.020 |
Why?
|
| Lorazepam | 1 | 2006 | 145 | 0.020 |
Why?
|
| Prejudice | 1 | 2010 | 569 | 0.020 |
Why?
|
| Substance Abuse, Intravenous | 1 | 2010 | 525 | 0.020 |
Why?
|
| Analgesics, Non-Narcotic | 1 | 2009 | 366 | 0.020 |
Why?
|
| Peru | 1 | 2008 | 882 | 0.020 |
Why?
|
| Treatment Failure | 1 | 2011 | 2617 | 0.020 |
Why?
|
| Patient Satisfaction | 2 | 2009 | 3391 | 0.020 |
Why?
|
| Physical Education and Training | 1 | 2005 | 106 | 0.020 |
Why?
|
| Outpatients | 1 | 2013 | 1488 | 0.020 |
Why?
|
| Verbal Behavior | 1 | 2006 | 340 | 0.020 |
Why?
|
| Infant Care | 1 | 2006 | 179 | 0.020 |
Why?
|
| Ibuprofen | 1 | 2006 | 236 | 0.020 |
Why?
|
| Widowhood | 1 | 2005 | 54 | 0.020 |
Why?
|
| Lymph Node Excision | 1 | 2011 | 1262 | 0.020 |
Why?
|
| Midazolam | 1 | 2006 | 270 | 0.020 |
Why?
|
| Phobic Disorders | 1 | 2007 | 439 | 0.020 |
Why?
|
| Genetic Association Studies | 1 | 2014 | 2703 | 0.020 |
Why?
|
| Child Behavior | 1 | 2010 | 831 | 0.010 |
Why?
|
| Nevirapine | 1 | 2005 | 267 | 0.010 |
Why?
|
| Sudan | 1 | 2003 | 83 | 0.010 |
Why?
|
| Twins, Dizygotic | 1 | 2004 | 235 | 0.010 |
Why?
|
| Causality | 1 | 2010 | 1275 | 0.010 |
Why?
|
| Propensity Score | 1 | 2010 | 1781 | 0.010 |
Why?
|
| Glycemic Index | 1 | 2006 | 394 | 0.010 |
Why?
|
| Urban Population | 1 | 2012 | 2021 | 0.010 |
Why?
|
| Suicidal Ideation | 1 | 2013 | 1246 | 0.010 |
Why?
|
| Fentanyl | 1 | 2006 | 409 | 0.010 |
Why?
|
| Hygiene | 1 | 2003 | 97 | 0.010 |
Why?
|
| Safety Management | 1 | 2009 | 782 | 0.010 |
Why?
|
| DNA-Binding Proteins | 1 | 2001 | 9648 | 0.010 |
Why?
|
| Feasibility Studies | 1 | 2013 | 5078 | 0.010 |
Why?
|
| Geography | 1 | 2005 | 669 | 0.010 |
Why?
|
| Lymphatic Metastasis | 1 | 2011 | 2924 | 0.010 |
Why?
|
| Twins, Monozygotic | 1 | 2004 | 458 | 0.010 |
Why?
|
| Animals | 4 | 2015 | 168660 | 0.010 |
Why?
|
| Urinary Bladder Neoplasms | 1 | 2015 | 2248 | 0.010 |
Why?
|
| Recovery of Function | 1 | 2013 | 2922 | 0.010 |
Why?
|
| Religion | 1 | 2006 | 356 | 0.010 |
Why?
|
| Chemotherapy, Adjuvant | 1 | 2011 | 3480 | 0.010 |
Why?
|
| Lung | 1 | 2001 | 9858 | 0.010 |
Why?
|
| Survivors | 1 | 2012 | 2291 | 0.010 |
Why?
|
| Inheritance Patterns | 1 | 2004 | 339 | 0.010 |
Why?
|
| Sociology, Medical | 1 | 2002 | 64 | 0.010 |
Why?
|
| Residence Characteristics | 1 | 2012 | 2050 | 0.010 |
Why?
|
| Monitoring, Physiologic | 1 | 2009 | 1738 | 0.010 |
Why?
|
| Uterine Cervical Neoplasms | 1 | 2014 | 2018 | 0.010 |
Why?
|
| Infant, Low Birth Weight | 1 | 2006 | 848 | 0.010 |
Why?
|
| Biomedical Research | 1 | 2017 | 3308 | 0.010 |
Why?
|
| Demography | 1 | 2006 | 1653 | 0.010 |
Why?
|
| Delivery of Health Care, Integrated | 1 | 2009 | 941 | 0.010 |
Why?
|
| Spirituality | 1 | 2006 | 405 | 0.010 |
Why?
|
| Electrocardiography | 1 | 2014 | 6441 | 0.010 |
Why?
|
| Transcription Factors | 1 | 2001 | 12209 | 0.010 |
Why?
|
| Anticonvulsants | 1 | 2011 | 1910 | 0.010 |
Why?
|
| Administration, Oral | 1 | 2009 | 3912 | 0.010 |
Why?
|
| Glomerular Filtration Rate | 1 | 2009 | 2167 | 0.010 |
Why?
|
| Early Growth Response Protein 1 | 1 | 2001 | 138 | 0.010 |
Why?
|
| Endoscopy | 1 | 2011 | 1781 | 0.010 |
Why?
|
| Occupations | 1 | 2003 | 517 | 0.010 |
Why?
|
| Minority Groups | 1 | 2008 | 1222 | 0.010 |
Why?
|
| Tuberculosis, Multidrug-Resistant | 1 | 2008 | 912 | 0.010 |
Why?
|
| Stroke | 1 | 2003 | 9975 | 0.010 |
Why?
|
| Caregivers | 1 | 2012 | 2098 | 0.010 |
Why?
|
| Siblings | 1 | 2004 | 853 | 0.010 |
Why?
|
| Grief | 1 | 2002 | 248 | 0.010 |
Why?
|
| Controlled Clinical Trials as Topic | 1 | 2000 | 186 | 0.010 |
Why?
|
| Genotype | 1 | 2014 | 12944 | 0.010 |
Why?
|
| Pelvic Bones | 1 | 2001 | 265 | 0.010 |
Why?
|
| Placebos | 1 | 2003 | 1674 | 0.010 |
Why?
|
| Vegetables | 1 | 2005 | 1181 | 0.010 |
Why?
|
| Administration, Inhalation | 1 | 2001 | 1105 | 0.010 |
Why?
|
| Exercise | 2 | 2005 | 5611 | 0.010 |
Why?
|
| Patient Care Team | 1 | 2010 | 2528 | 0.010 |
Why?
|
| Syndrome | 1 | 2004 | 3249 | 0.010 |
Why?
|
| Quality Assurance, Health Care | 1 | 2008 | 2211 | 0.010 |
Why?
|
| Sleep | 1 | 2013 | 4619 | 0.010 |
Why?
|
| Mycobacterium tuberculosis | 1 | 2008 | 1832 | 0.010 |
Why?
|
| Wounds and Injuries | 1 | 2010 | 2401 | 0.010 |
Why?
|
| Premenopause | 1 | 2001 | 1033 | 0.010 |
Why?
|
| Ambulatory Care | 1 | 2008 | 2707 | 0.010 |
Why?
|
| Infant, Premature | 1 | 2006 | 2031 | 0.010 |
Why?
|
| Pneumonia | 1 | 2007 | 2133 | 0.010 |
Why?
|
| Breast Feeding | 1 | 2003 | 1338 | 0.010 |
Why?
|
| Disease Management | 1 | 2006 | 2459 | 0.010 |
Why?
|
| Femur | 1 | 2001 | 1296 | 0.010 |
Why?
|
| Patient Discharge | 1 | 2007 | 3317 | 0.010 |
Why?
|
| Magnetic Resonance Imaging | 1 | 2021 | 35409 | 0.010 |
Why?
|
| Neoplasms | 1 | 2002 | 21675 | 0.010 |
Why?
|
| Air Pollutants | 1 | 2006 | 2816 | 0.010 |
Why?
|
| Lumbar Vertebrae | 1 | 2001 | 1848 | 0.010 |
Why?
|
| Mice | 2 | 2001 | 81154 | 0.010 |
Why?
|
| Blood Glucose | 1 | 2006 | 6259 | 0.010 |
Why?
|
| Personality Tests | 1 | 1990 | 83 | 0.010 |
Why?
|
| Heart | 1 | 2002 | 4460 | 0.010 |
Why?
|
| Brain | 1 | 2015 | 26345 | 0.000 |
Why?
|
| Phenotype | 1 | 2004 | 16361 | 0.000 |
Why?
|
| Diet | 1 | 2003 | 7930 | 0.000 |
Why?
|
| Attitude | 1 | 1990 | 775 | 0.000 |
Why?
|
| Mice, Inbred C57BL | 1 | 2001 | 21824 | 0.000 |
Why?
|
| Myocardial Infarction | 1 | 2003 | 11708 | 0.000 |
Why?
|
| Antineoplastic Agents | 1 | 2002 | 13691 | 0.000 |
Why?
|